The Archbishop of Liverpool Malcolm McMahon formally recognised the cure of John Traynor during the archdiocese’s first ...

RAMAT GAN, Israel, Dec. 04, 2024 (GLOBE NEWSWIRE) -- (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a ...

CF602, the Company's third drug candidate, has shown efficacy in the treatment of erectile dysfunction ... into clinical trials or to successfully complete our preclinical studies or clinical ...

good quality of life and is defined as a long term complete response. Namodenoson has Orphan Drug status with both the FDA and EMA, as well as Fast Track Status with the FDA for the treatment of ...